Yunnan Botanee Bio-Technology Group Co.LTD (300957.SZ)
CNY 42.2
(-1.52%)
CNY 42.2
(-1.52%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.44 Billion CNY | 29.2% |
| 2022 | 1.11 Billion CNY | 8.02% |
| 2021 | 1.03 Billion CNY | 158.47% |
| 2020 | 400.05 Million CNY | 23.92% |
| 2019 | 322.81 Million CNY | 3.1% |
| 2018 | 313.1 Million CNY | 30.79% |
| 2017 | 239.39 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 951.21 Million CNY | -34.08% |
| 2024 Q2 | 1.6 Billion CNY | 68.55% |
| 2024 Q3 | 1.75 Billion CNY | 9.62% |
| 2023 Q2 | 934.51 Million CNY | 34.42% |
| 2023 FY | 1.44 Billion CNY | 29.2% |
| 2023 Q4 | 1.44 Billion CNY | 37.58% |
| 2023 Q3 | 1.04 Billion CNY | 12.24% |
| 2023 Q1 | 695.21 Million CNY | -37.76% |
| 2022 Q3 | 983.25 Million CNY | 0.13% |
| 2022 Q2 | 981.98 Million CNY | 29.1% |
| 2022 FY | 1.11 Billion CNY | 8.02% |
| 2022 Q1 | 760.61 Million CNY | -26.44% |
| 2022 Q4 | 1.11 Billion CNY | 13.6% |
| 2021 Q3 | 704.79 Million CNY | 22.58% |
| 2021 FY | 1.03 Billion CNY | 158.47% |
| 2021 Q4 | 1.03 Billion CNY | 46.71% |
| 2021 Q2 | 574.96 Million CNY | 80.41% |
| 2021 Q1 | 318.7 Million CNY | -20.33% |
| 2020 Q4 | 400.05 Million CNY | -4.18% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 FY | 400.05 Million CNY | 23.92% |
| 2020 Q3 | 417.48 Million CNY | 12.91% |
| 2020 Q2 | 369.74 Million CNY | 0.0% |
| 2019 FY | 322.81 Million CNY | 3.1% |
| 2019 Q4 | 322.81 Million CNY | 0.0% |
| 2018 FY | 313.1 Million CNY | 30.79% |
| 2017 FY | 239.39 Million CNY | 0.0% |